science

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

Science Daily · May 21, 2026, 1:02 PM · Also reported by 4 other sources

Why this matters: new research or scientific developments with potential real-world impact.

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these medications could become a major weapon against cardiovascular disease — not just obesity and diabetes.

Read full story on Science Daily → More top stories

Also covered by

ABC Australia What is broken heart syndrome and who is most at risk? MarketWatch Lilly’s new experimental shot produced 28% weight loss NY Times Experimental Drug Yields Dramatic Weight Loss Healthline ‘Next-Gen’ GLP-1 Leads to 16% More Weight Loss. Is It Better Than Zepbound?

Aggregated and edited by the Scoop newsroom. We surface news from Science Daily alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

Also covered by

More in science